Year
Month

(Peer-Reviewed) Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort
Tingting Liu 刘婷婷 ¹, Jing Dai ², Zhitao Yang 杨志涛 ³, Xiaoqi Yu ⁴, Yanping Xu ⁵ ⁶ ⁷, Xinming Shi ², Dong Wei ⁴, Zihan Tang ¹, Guanqun Xu 徐冠群 ², Wenxin Xu ⁴, Yu Liu ², Ce Shi ², Qi Ni 倪琪 ², Chengde Yang 杨程德 ¹, Xinxin Zhang 张欣欣 ⁴, Xuefeng Wang 王学锋 ², Erzhen Chen 陈尔真 ³, Jieming Qu 瞿介明 ⁵ ⁶ ⁷
¹ Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院附属瑞金医院 风湿免疫科
² Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院附属瑞金医院 检验科
³ Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院附属瑞金医院 急诊科
⁴ Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院附属瑞金医院 感染科 临床病毒学研究室
⁵ Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院附属瑞金医院 呼吸与危重症医学科
⁶ Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 上海交通大学医学院 呼吸疾病研究所
⁷ Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
Science Bulletin , 2021-07-27
Abstract

The presence of antiphospholipid antibodies was shown to be associated with thrombosis in coronavirus disease 2019 (COVID-19) patients. Recently, according to reports from several studies, the vaccine-induced immune thrombotic thrombocytopenia is mediated by anti-platelet factor 4 (PF4)-polyanion complex in adenovirus-vectored COVID-19 vaccine recipients. It is impendent to explore whether inactivated COVID-19 vaccine widely used in China influences prothrombotic autoantibody production and induces thrombosis.

In this prospective study, we recruited 406 healthcare workers who received two doses, 21 days apart, of inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (BBIBP-CorV, Sinopharm). Paired blood samples taken before vaccination and four weeks after the second vaccination were used in detecting prothrombotic autoantibodies, including anticardiolipin (aCL), anti-β2 glycoprotein I (aβ2GP1), anti-phosphatidylserine/prothrombin (aPS/PT), and anti-PF4-heparin.

The seroconversion rate of SARS-CoV-2 specific antibodies was 95.81% (389/406) four weeks after vaccination. None of the subjects had spontaneous thrombosis or thrombocytopenia over a minimum follow-up period of eight weeks. There was no significant difference in the presence of all ten autoantibodies between samples collected before and after vaccination: for aCL, IgG (7 vs. 8, P = 0.76), IgM (41 vs. 44, P = 0.73), IgA (4 vs. 4, P = 1.00); anti-β2GP1, IgG (7 vs. 6, P = 0.78), IgM (6 vs. 5, P = 0.76), IgA (3 vs. 5, P = 0.72); aPS/PT IgG (0 vs. 0, P = 1.00), IgM (6 vs. 5, P = 0.76); aPF4-heparin (2 vs. 7, P = 0.18), and antinuclear antibody (ANA) (18 vs. 21, P = 0.62).

Notably, seven cases presented with anti-PF4-heparin antibodies (range: 1.18–1.79 U/mL) after vaccination, and none of them exhibited any sign of thrombotic disorder. In conclusion, inactivated SARS-CoV-2 vaccine does not influence the profile of antiphospholipid antibody and anti-PF4-heparin antibody nor increase the risk of thrombosis.
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort_1
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort_2
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort_3
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort_4
  • High-speed and large-capacity visible light communication for 6G: advances and perspectives
  • Nan Chi, Zhilan Lu, Fujie Li, Haoyu Zhang, Yunkai Wang, Xinyi Liu, Zhiwu Chen, Zhe Feng, Zhuoran Hu, Zhixue He, Ziwei Li, Chao Shen, Junwen Zhang
  • Opto-Electronic Technology
  • 2026-03-20
  • Multi-dimensional photodetection: from material intrinsic properties and metasurface engineering to silicon photonic integration
  • Wenqi Liu, Zilan Tang, Qingzhao Hua, Liang Liu, Xiaoxia Wang, Anlian Pan
  • Opto-Electronic Technology
  • 2026-03-20
  • Holotomography-driven learning unlocks in-silico staining of single cells in flow cytometry by avoiding fluorescence co-registration
  • Daniele Pirone, Giusy Giugliano, Michela Schiavo, Annalaura Montella, Martina Mugnano, Vincenza Cerbone, Maddalena Raia, Giulia Scalia Ivana Kurelac, Diego Luis Medina, Lisa Miccio Mario Capasso, Achille Iolascon, Pasquale Memmolo, Pietro Ferraro
  • Opto-Electronic Science
  • 2026-02-25
  • Narrow beam and low-sidelobe electro-optic beam steering on thin-film lithium niobate optical phased array
  • Yang Li, Shiyao Deng, Xiao Ma, Ziliang Fang, Shufeng Li Weikang Xu, Fangheng Fu, Xu Ouyang, Yuming Wei, Tiefeng Yang Heyuan Guan, Huihui Lu
  • Opto-Electronic Science
  • 2026-02-25
  • Scene-level passive polarization 3D imaging
  • Xin Wang, Pingli Han, Xiyuan Luo, Qianqian Liu, Tong Zhang, Xue Dong, Meng Xiang, Jinpeng Liu, Yanyan Liu, Fei Liu
  • Opto-Electronic Advances
  • 2026-02-12
  • Modelling-guided inverse design strategy for semitransparent perovskite photovoltaics with customized colors
  • Seok-Beom Seo, Rira Kang, Eun-Joo Lee, So-Yeon Ju, Min Jae Lee, Byunghong Lee, Sun-Kyung Kim
  • Opto-Electronic Advances
  • 2026-02-12
  • A hybrid integrated high-precision tunable semiconductor laser
  • Yiran Zhu, Botao Fu, Zhiwei Fang, Qiyue Hu, Jianping Yu, Yunpeng Song, Yu Ma, Min Wang, Kunpeng Jia, Zhenda Xie, Ya Cheng
  • Opto-Electronic Advances
  • 2026-02-12
  • Soft chiral superstructure enabled dynamic polychromatic holography
  • Chun-Ting Xu, Lu Li, Quan-Ming Chen, Guang-Yao Wang, Wei Hu
  • Opto-Electronic Advances
  • 2026-02-12
  • Millisecond-level electrically switchable metalens for adaptive rotational depth mapping and diffraction-limited imaging
  • Yeseul Kim, Jihae Lee, Won-Sik Kim, Hyeonsu Heo, Dongmin Jeon, Beomha Yang, Xiaotong Li, Harit Keawmuang, Shiqi Hu, Young-Ki Kim, Trevon Badloe, Junsuk Rho
  • Opto-Electronic Advances
  • 2026-02-12
  • Ambient-energy-driven space-time-coding metasurface for space-frequency-division multiplexing wireless communications
  • Han Wei Tian, Chao Song, Dong Jie Wang, Qian Zhu, Tie Jun Cui, Wei Xiang Jiang
  • Opto-Electronic Advances
  • 2026-02-12
  • Ultra-sensitive multi-band infrared polarization photodetector based on 1T'-MoTe₂/2H-MoTe₂ van der Waals heterostructure
  • Yuting Pan, Lidan Lu, Bofei Zhu, Chunhua An, Jing Yu, Guanghui Ren, Jian Zhen Ou, Mingli Dong, Zheng You, Lianqing Zhu
  • Opto-Electronic Advances
  • 2026-02-09
  • Tunable compound eyes with coaxial lens-on-lens ommatidia for cooperative bi-focal imaging
  • Zhi-Juan Sun, Wei-Jian Zhong, Qing Cai, Yi-Fan Lu, Chang-Xu Li, Dong-Dong Han, Yong-Lai Zhang
  • Opto-Electronic Advances
  • 2026-02-09



  • The COVID-19 Pandemic, Regional Cooperation Economic Partnership (RCEP) and the Rise of Investment Facilitation        Non-spreading bessel spatiotemporal optical vortices
    About
    |
    Contact
    |
    Copyright © PubCard